BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Citi
Mallinckrodt
Dow
Cipla
US Army
Federal Trade Commission
Baxter
Express Scripts
Moodys

Generated: January 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,700,076

« Back to Dashboard

Summary for Patent: 7,700,076
Title:Penetrating pharmaceutical foam
Abstract: The invention relates to an alcohol-free cosmetic or pharmaceutical foam composition comprising water, a hydrophobic solvent, a surface-active agent, a gelling agent, an active component selected from the group of urea, hydroxy acid and a therapeutic enhancer and a propellant. The foam further comprises active agents and excipients with therapeutic properties having enhanced skin penetration.
Inventor(s): Tamarkin; Dov (Maccabim, IL), Friedman; Doron (Karmei Yosef, IL), Eini; Meir (Ness Ziona, IL)
Assignee: Foamix, Ltd. (Ness Ziona, IT)
Application Number:10/922,358
Patent Claim Types:
see list of patent claims
Composition; Compound; Delivery;

Drugs Protected by US Patent 7,700,076

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Bayer Hlthcare FINACEA azelaic acid AEROSOL, FOAM;TOPICAL 207071-001 Jul 29, 2015 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 7,700,076

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Israel152486Oct 25, 2002

Non-Orange Book US Patents Family Members for Patent 7,700,076

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,114,385 Oleaginous pharmaceutical and cosmetic foam ➤ Subscribe
8,486,376 Moisturizing foam containing lanolin ➤ Subscribe
8,900,554 Foamable composition and uses thereof ➤ Subscribe
2,010,040,561 ➤ Subscribe
9,211,259 Antibiotic kit and composition and uses thereof ➤ Subscribe
9,050,253 Oleaginous pharmaceutical and cosmetic foam ➤ Subscribe
8,362,091 Foamable vehicle and pharmaceutical compositions thereof ➤ Subscribe
8,741,265 Penetrating pharmaceutical foam ➤ Subscribe
8,722,021 Foamable carriers ➤ Subscribe
8,518,378 Oleaginous pharmaceutical and cosmetic foam ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,700,076

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2003279493 ➤ Subscribe
Australia 2004261063 ➤ Subscribe
Australia 2004266502 ➤ Subscribe
Australia 2004313285 ➤ Subscribe
Australia 2004321183 ➤ Subscribe
Australia 2005204341 ➤ Subscribe
Australia 2005204347 ➤ Subscribe
Australia 2006201878 ➤ Subscribe
Australia 2006273697 ➤ Subscribe
Australia 2006283225 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Express Scripts
Novartis
Cantor Fitzgerald
QuintilesIMS
Harvard Business School
Teva
Baxter
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot